ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 139,35
-0,94%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AN2 Therapeutics Inc (ANTX)

  7. AN2 Therapeutics Inc (ANTX) Actualités

ANTX AN2 Therapeutics Inc

2,40
0,12 (5,26%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
AN2 Therapeutics Inc ANTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,12 5,26% 2,40 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,30 2,20 2,37 2,32 2,28
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/3/202421:10BWAN2 Therapeutics Reports Fourth Quarter and Full Year 2023..
13/2/202423:11EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202413:01EDGAR2Form 8-K - Current report
12/2/202412:45BWAN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase..
30/1/202422:10BWAN2 Therapeutics to Present at Oppenheimer Healthcare Life..
19/1/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:45EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:36EDGAR2Form 144 - Report of proposed sale of securities
17/11/202300:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:10EDGAR2Form 8-K - Current report
09/11/202322:05BWAN2 Therapeutics Reports Third Quarter 2023 Financial..
06/11/202313:00BWAN2 Therapeutics to Present at Upcoming Investor Conferences
18/10/202313:00BWAN2 Therapeutics Signs License Agreement with the University..
11/10/202306:01BWAN2 Therapeutics to Present New Data for Epetraborole at..
04/10/202301:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:10EDGAR2Form 144 - Report of proposed sale of securities
29/9/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:11EDGAR2Form 144 - Report of proposed sale of securities
26/9/202313:00BWAN2 Therapeutics Signs Grant Agreement to Discover Novel,..
15/9/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202314:00EDGAR2Form 8-K - Current report
13/9/202313:00BWAN2 Therapeutics commences Phase 3 Part of Phase 2/3..
08/9/202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:14EDGAR2Form 144 - Report of proposed sale of securities
16/8/202322:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/8/202322:47EDGAR2Form 8-K - Current report
16/8/202304:42BWAN2 Therapeutics Announces Pricing of $70.0 Million..
10/8/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:18EDGAR2Form 8-K - Current report
10/8/202322:10BWAN2 Therapeutics Reports Second Quarter 2023 Financial..
25/5/202322:10BWAN2 Therapeutics to Present at Jefferies Healthcare..
11/5/202322:10BWAN2 Therapeutics Reports First Quarter 2023 Financial..
01/5/202313:00BWAN2 Therapeutics to Present at JMP Securities Life Sciences..

Dernières Valeurs Consultées

NASDAQ
ANTX
AN2 Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés